Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | AZN | AMGN | GILD | BMY |
| Company | Ultragenyx Pharmaceu | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 24.90 | 185.45 | 332.52 | 130.00 | 60.02 |
| High | 25.11 | 187.18 | 337.00 | 132.36 | 60.09 |
| Low | 24.36 | 184.01 | 324.63 | 129.01 | 58.03 |
| Latest | 24.77 | 184.74 | 329.82 | 131.65 | 58.22 |
| Change | +0.08 | -2.63 | -16.43 | +0.81 | -2.37 |
| % Change | +0.32% | -1.40% | -4.75% | +0.62% | -3.91% |
| Volume | 1,407,200 | 1,793,600 | 3,821,000 | 5,517,100 | 18,368,400 |
| 20-Day Average Volume | 1,635,790 | 2,037,180 | 2,556,970 | 5,343,460 | 9,848,785 |
| Previous Close | 24.69 | 187.37 | 346.25 | 130.84 | 60.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.17 | 196.74 | 346.03 | 135.57 | 58.75 |
| 20-Day Raw Stochastic | 63.68% | 11.77% | 14.91% | 26.16% | 28.09% |
| 20-Day Relative Strength | 56.93 | 39.54 | 38.29 | 41.28 | 48.14 |
| Weighted Alpha | -17.09 | +23.61 | +13.61 | +22.30 | +19.71 |
| Today's Opinion | 24% Sell | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Previous Opinion | 24% Sell | 40% Buy | 8% Buy | Hold | 72% Buy |
| Last Month's Opinion | 88% Sell | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.78% since 04/24/26 | -2.64% since 04/24/26 | -4.28% since 04/24/26 | +0.96% since 04/24/26 | -0.83% since 04/24/26 |
| Low | 23.71 on 04/29/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 25.14 on 04/28/26 | 190.59 on 04/27/26 | 349.54 on 04/30/26 | 132.36 on 05/01/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +15.64% since 04/01/26 | -7.97% since 04/01/26 | -6.64% since 04/01/26 | -6.17% since 04/01/26 | -5.69% since 04/01/26 |
| Low | 20.79 on 04/02/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 26.19 on 04/16/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +2.91% since 01/30/26 | -0.43% since 01/30/26 | -3.53% since 01/30/26 | -7.26% since 01/30/26 | +5.76% since 01/30/26 |
| Low | 18.29 on 03/24/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 26.19 on 04/16/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -28.41% since 10/31/25 | +12.10% since 10/31/25 | +10.52% since 10/31/25 | +9.90% since 10/31/25 | +26.37% since 10/31/25 |
| Low | 18.29 on 03/24/26 | 160.96 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 39.89 on 12/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,435,064 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 98,307 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 673,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -575,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 207,280,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -128,560,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.38 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.29 on 02/12/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/05/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |